Purified Exosome Product (PEP) Injected Into the Hypodermis
Clinical trial NCT06429033 · COMPLETED
Trial details
- NCT number
- NCT06429033
- Sponsor
- Clinical Testing of Beverly Hills
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-14
- Primary completion
- 2025-12-17
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.